Tracking Extended-spectrum β-lactamase-Producing and Colistin-Resistant Escherichia coli in Pig Abattoirs: Impacts on Food Safety
Foodborne Pathogens and Disease · 2026
DOI: 10.1089/fpd.2024.0178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foodborne Pathogens and Disease, 2026. Verfasst von Imporn Saenkankam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Escherichia coli, Abattoirs, Colistin, beta-Lactamases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
The ongoing increase in antimicrobial resistance (AMR) in Escherichia coli , particularly the emergence of extended-spectrum β-lactamase (ESBL)-producing and colistin-resistant strains in livestock, is a significant public health concern. The effectiveness of pig abattoir management, specifically through Hazard Analysis and Critical Control Points (HACCP) protocols, in reducing antimicrobial-resistant contamination continues to be scrutinized. This study investigated the prevalence, characteristics, and critical contamination points of ESBL-producing E. coli (ESBL-Ec) and colistin-resistant ESBL-Ec across the slaughtering processes in two pig abattoirs in Thailand—one operating under HACCP standards and the other certified solely under Good Manufacturing Practices. A higher prevalence of ESBL-Ec was found in the non-HACCP facility (67.98%) compared with the HACCP facility (52.04%), especially in pig carcasses. Skin and carcass washing in HACCP facilities effectively decreased bacterial contamination. Conversely, non-HACCP facilities should implement measures such as cleaning skin with disinfectants at the lairage, regularly monitoring and adjusting the final washing protocol, and strict sterilization of chopping plates to effectively control contamination points. Most ESBL-Ec isolates were multidrug-resistant and carried bla CTX-M group 1 or group 9 genes. Additionally, 12.6% of these isolates were resistant to colistin, with the mcr-1 gene predominantly identified. ST10 was the dominant clone of mcr -carrying ESBL-Ec across various slaughtering stages and sample types. These findings highlight the importance of implementing HACCP protocols to reduce contamination, enhance food safety, and mitigate public health risks. Ongoing AMR monitoring to find critical points along the slaughtering process is essential to reduce sources of AMR transmission to consumers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
- Veterinary Pathobiology Graduate Program, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
- School of Veterinary Medicine, Murdoch University, Perth, Australia.
- Center of Excellence in Diagnosis and Monitoring of Animal Pathogens (DMAP), Bangkok, Thailand.
ORCID-Profile: Nuvee Prapasarakul
Zitieren
APA
Saenkankam, I., Apiwatsiri, P., Supimon, N., Niyomtham, W., Hampson, D. J., & Prapasarakul, N. (2026). Tracking Extended-spectrum β-lactamase-Producing and Colistin-Resistant Escherichia coli in Pig Abattoirs: Impacts on Food Safety. Foodborne Pathogens and Disease. https://doi.org/10.1089/fpd.2024.0178
Vancouver
Saenkankam I, Apiwatsiri P, Supimon N, Niyomtham W, Hampson DJ, Prapasarakul N. Tracking Extended-spectrum β-lactamase-Producing and Colistin-Resistant Escherichia coli in Pig Abattoirs: Impacts on Food Safety. Foodborne Pathogens and Disease. 2026. doi:10.1089/fpd.2024.0178
BibTeX
@article{Saenkankam2026,
author = {Saenkankam, Imporn and Apiwatsiri, Prasert and Supimon, Natthapong and Niyomtham, Waree and Hampson, David J and Prapasarakul, Nuvee},
title = {Tracking Extended-spectrum β-lactamase-Producing and Colistin-Resistant Escherichia coli in Pig Abattoirs: Impacts on Food Safety},
journal = {Foodborne Pathogens and Disease},
year = {2026},
doi = {10.1089/fpd.2024.0178}
}
EUVIMED